Day: March 21, 2025

Sláturfélag Suðurlands svf Niðurstöður aðalfundar Sláturfélags Suðurlands svf. Aðalfundur Sláturfélags Suðurlands var haldinn föstudaginn 21. mars 2025 kl. 15:00 að Goðalandi, Fljótshlíð. 1. ÁrsreikningurAðalfundur samþykkti ársreikning félagsins vegna ársins 2024. 2. Tillaga stjórnar um vexti af stofnsjóði og greiðslu arðs samþykktStjórn Sláturfélags Suðurlands svf. leggur til við aðalfund að greiddur verði 14,77% arður af B-deild stofnsjóðs, þar af er verðbótaþáttur 4,77% skv. 1. mgr. 14. gr. samþykkta félagsins, alls kr. 29.530.179,- eða 0,1477 kr. á hvern útgefin hlut. Jafnframt að reiknaðir verði 14,77% vextir á höfuðstól inneigna í A-deild stofnsjóðs, alls kr. 64.063.952,- Arðleysisdagur er 24. mars og arðréttindadagur er 25. mars. Greiðsludagur arðs er 28. mars n.k. 3. Kosning stjórnarStjórn félagsins eftir kosningar skipa eftirtaldir: Aðalmenn:...

SASKATOON, Saskatchewan, March 21, 2025 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has acquired strategic claims within the Company’s Pen Gold Project located west of Timmins, ON. The Company paid a total purchase price of C$4,500 to acquire a 100% ownership of the claims. In addition, and pursuant to the Company’s annual executive compensation program, the Company announces that it has granted stock options to directors and officers to purchase up to an aggregate of 3,812,000 common shares of the Company. The stock options have various vesting periods and are exercisable for a period of five years at a price of $0.195 per common share, being the closing price on March 17, 2025. All options were granted pursuant to the Company’s stock option plan. Lastly, as previously reported on...

NEWPORT BEACH, Calif., March 21, 2025 (GLOBE NEWSWIRE) — PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”), a diversified holding company, today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 294,450 of the Company’s common stock, par value $0.0001 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $5.04 per share in a registered direct offering priced at-the-market under Nasdaq. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share. Following the offering the Company will have approximately 872,411 shares of common stock issued and outstanding. The aggregate gross proceeds to the Company in this offering are expected to...

HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no material development in its business affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action regarding its share price. About Impact BioMedical, Inc.: Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. Safe Harbor Disclosure: This press release contains...

Press release21 March 2025 – N° 05   COMBINED SHAREHOLDERS’ MEETING TO BE HELDON TUESDAY 29 APRIL 2025 AVAILABILITY OF THE DOCUMENTS The shareholders of SCOR SE (the “Company”) are invited to the Combined Shareholders’ Meeting to be held on: Tuesday 29 April 2025at 10:30 a.m. (Paris time)at the headquarters of SCOR SE5, avenue Kléber75016 ParisFrance The notice of meeting (avis de réunion) was published today in the Bulletin des Annonces Légales Obligatoires (Bulletin n° 35) and contains the agenda and the text of the resolutions to be submitted to the vote of this Combined Shareholders’ Meeting. Holders of bearer shares should ask their financial intermediaries for proxy or distance voting forms. Holders of registered shares will receive these forms with their convening notice. Information relating to this Combined Shareholders’...

Paris, le 21 mars 2025 Mise à disposition du document d’enregistrement universel 2024 et du rapport financier annuel du Groupe BPCE Le Groupe BPCE informe que le document d’enregistrement universel 2024 a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 21 mars 2025 sous le n° D.25-0132. Ce document est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur. Il peut être également consulté à la rubrique « Résultats et publications » de l’espace « Investisseur » du site internet du Groupe BPCE https://groupebpce.com/investisseurs/resultats-et-publications/documents-de-referenceAttachmentURD2024_Communiqué_mise_a_disposition

Volta Finance Limited (VTA / VTAS)February 2025 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES Guernsey, March 21st, 2025 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for February 2025. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). Performance and Portfolio Activity Dear Investors, Volta Finance’s net performance for the month of February established at +1.6%, taking the Aug 2024-to-date performance at +13.1%. Both our investments in CLO Debt and CLO Equity performed positively over the course of the month, with European CLO Equities benefiting from a strong price appreciation despite market volatility. Volatility intensified in February as US...

Ghent, 21 March 2025 – 18:30 – Press release / Regulated information On 26 December 2024, the Extraordinary General Meeting of ABO-Group Environment NV approved a capital decrease of €993,461.09, with the aim of achieving a distribution to shareholders, through repayment on each share of 1/10,568,735th of the amount of the capital decrease. This amounts to the payment of a shareholder remuneration of €0.094 per share, in accordance with the positive opinion of the Ruling Committee obtained by the Company. The following dates were set:Ex-date on 21 March 2025 – from this date, the Company’s shares will be traded on Euronext Brussels ex-coupon No 2; Registration date on 24 March 2025; and Payment date on 25 March 2025.Payment of the capital decrease will be made by the Company for nominative shareholders and through...

HORSHAM, Pa., March 21, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report fourth quarter and year end 2024 financial results on Thursday, March 27, 2025 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Thursday, March 27, 2025 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. To listen to the conference call, interested parties within the U.S. should dial 1-844-481-2523 (domestic) or 1-412-317-0552 (international). All callers should dial in approximately 10...